ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Kabra Drugs Ltd reported revenue from operations of ₹32 Cr (+61.6% YoY) and net profit of ₹1.9 Cr (+5.6% YoY) for Q2 FY27.
Kabra Drugs (now Aanjaay Industries) intimated a board meeting on 6 November 2026 to consider unaudited results for the quarter ended 30 September 2026. The filing is advance notice only.
The company has filed its quarterly shareholding pattern for the period ending September 30, 2026. The document discloses the distribution of shareholding among various categories of investors.
Aanjaay Industries Limited conducted its 37th Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and director appointments.